Slide 1

Slide 2

1 Sec. 69/21/11 If you click on the red arrow, you will skip to a view of Tevas stock chart

Slide 3

As a worldwide generic pharmaceuticals leader, Teva is one of the top 15 pharmaceutical companies in the world. Its headquarters are located in Israel while Teva has operations within 60 other countries and carrys a collection of 42,000 employees worldwide. Teva takes great pride in its long tradition of leadership and dedication to excellence in service; originating from the companys founding year in 1901. 09/21/11Ryan Moore CIS 10552

Slide 4

Branded products are categorized into CNS (Central Nervous System) products, Respiratory products, Womens Health products, and BioSimilars products. Teva's CNS products include COPAXONE (glatiramer acetate injection), the world's top selling treatment for relapsing-remitting multiple sclerosis (RRMS), and AZILECT(rasagiline tablets), a treatment for Parkinson's disease. Teva's high-quality treatment options for people with respiratory disorders are designed to accommodate patients' preferences and improve convenience and ease of use. Teva is committed to help women live better, healthier and longer lives. We develop effective drugs, products and interventional medical treatments that benefit women throughout their lifecycle. Teva aspires to broaden the access to life saving biologic treatments, making them available and obtainable for more people around the world. Other than Teva owning branded products, it is also the No. 1 generic company in the world. 63 Billion tablets and capsules were manufactured in 2010 and there has been over 600 million prescriptions affiliated with Teva. 09/21/11Ryan Moore CIS 10553

Slide 5

09/21/11Ryan Moore CIS 10554 1 Production begins according to GMP (Good Manufacturing Practice) regulations to ensure the absolute highest standards of quality. 2 Once production is completed, products are distributed to Teva's customers around the world including; pharmacies and pharmacy chains, hospitals, health-insurers, wholesalers and more. 3 Teva's vast supply chain once again succeeds in meeting the most challenging deadlines by land, sea, or air.

Slide 6

Teva comments on Supreme Court Decision - 6/23/2011 Teva is pleased with the High Court's decision today, which provides great clarity for both the drug industry as well as patients. Teva Signs $4 Billion Syndicated Credit Facilities - 6/13/2011 Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced today that it has entered into Syndicated Credit Facilities totaling $4 billion supporting the $6.8 billion acquisition of Cephalon, Inc. Teva Announces Launch of Camrese - 7/28/2011 Teva Pharmaceuticals USA, the U.S.based generic arm of Teva Pharmaceuticals announced that it will sell Camrese as the Authorized Generic of Seasonique which is also manufactured by Teva Pharmaceuticals. This product will continue to be manufactured under the brand products new drug application or NDA at the same facility where it is currently produced. 09/21/11Ryan Moore CIS 10555

Slide 7

Balance Sheet (at a glance) in Millions Sales by Channel [ Drug store chains - 54% of net sales Drug wholesalers - 33% of net sales Managed care organizations - 6% of net sales Generic distributors - 6% of net sales Governmental facilities and others - 1% of net sales Business Growth - FY 2009 (ended December 31, 2009) Net sales increased 25% to $13.9 billion. Net income more than doubled to $2 billion, compared to $609 million in the previous year. 09/21/11Ryan Moore CIS 10556

Slide 8

09/21/11Ryan Moore CIS 10557 Investment is part of Teva's strategy to expand its branded activities into specialty therapeutic areas. If Tevas stock chart is clicked, you will be taken back to the first slide of the presentation.

Slide 9

Organizational Hierarchy President and CEO Schlomo Yanai Chief Financial Officer Eyal Desheh Corporate Vice President/Chief Legal Officer/Company Secretary Richard S. Egosi Corporate Vice President/Head of Business Development Prof. Itzhak Krinsky HR and Chief Integration Officer Ika (Issac) Abravanel 09/21/11Ryan Moore CIS 10558 Organizational Structure Teva's organizational structure is an emblem of Teva's fundamental business strategy, highlighting our global strength and our pharmaceutical diversity. It enables us to continue to expand our core generic business across all geographies and leverage our global reach and scientific strength to develop new innovative products and technologies.

Slide 10

Visit the companys main webpage http://www.tevapharm.com in order to discover more information and enter an in depth look into the workings behind the success of Teva. http://www.tevapharm.com Also visit http://finance.yahoo.com/q?s=TEVA or http://www.hoovers.com/company/Teva_Pharm aceuticals_USA/rrrsyhi-1.html for stock and financial information about Teva Pharmecudical Works.http://finance.yahoo.com/q?s=TEVA http://www.hoovers.com/company/Teva_Pharm aceuticals_USA/rrrsyhi-1.html 09/21/11Ryan Moore CIS 10559 (Works Cited)